Clinical trials
Osteonecrosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Unknown status | 5 |
| Enrolling by invitation | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zimmer Biomet | 8 |
| DePuy International | 5 |
| MicroPort Orthopedics Inc. | 3 |
| BG Trauma Center Ludwigshafen | 2 |
| Medacta International SA | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Aesculap AG | 1 |
| Exactech | 1 |
| Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu | 1 |
| Texas Scottish Rite Hospital for Children | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteonecrosis | 26 |
| Osteoarthritis | 17 |
| Arthritis, Rheumatoid | 13 |
| Hip Dislocation, Congenital | 6 |
| Collagen Diseases | 4 |
| Slipped Capital Femoral Epiphyses | 4 |
| Ankylosis | 3 |
| Arthritis | 3 |
| Joint Diseases | 3 |
| Fractures, Bone | 2 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.